Serotonergic modulation of acetylcholine release from cortex of freely moving rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1219-1225

  Giovannini, Maria Grazia ^a   Ceccarelli, Ilaria ^a   Molinari, Beatrice ^a   Cecchi, Marco ^a   Goldfarb, Joseph ^b   Blandina, Patrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ACETYLCHOLINE; PHENYLBIGUANIDE; POTASSIUM; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TETRODOTOXIN; TROPISETRON;

ACETYLCHOLINE RELEASE; ARTICLE; BRAIN CORTEX; COGNITION; DRUG EFFECT; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM;

ACETYLCHOLINE; ANIMALS; BIGUANIDES; CEREBRAL CORTEX; HIPPOCAMPUS; INDOLES; MALE; POTASSIUM; RATS; RATS, WISTAR; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TETRODOTOXIN;

EID: 0031862951     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338:762-763.
2. 3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955-962.
3. 3 recognition sites. J Pharm Pharmacol 40:548-551.
4. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ and Blackburn TP (1995) Cloning and functional expression of a human 5-hydroxytryptamine type 3As receptor subunit. Mol Pharmacol 48:1054-1062.
5. Ben-Harari RR, Dalton B, Kaplan J and Maayani S (1987) Kinetic characterization of desensitization of the response to 5-hydroxytryptamine in airway and vascular tissue. Soc Neurosci Abst 13:343.
6. Benuck M and Reith ME (1992) Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn Schmiedeberg Arch Pharmacol 345:666-672.
7. 3 agonists decrease acetylcholine efflux from the cerebral cortex of freely moving guinea-pigs. Br J Pharmacol 101:448-452.
8. 3 receptor activation in rats. Br J Pharmacol 119: 1656-1664.
9. 3 receptors in rat striatum. J Pharmacol Exp Ther 251:803-809.
10. 3 receptor releases dopamine from rat striatal slice. Eur J Pharmacol 155:349-350.
11. Blandina P, Goldfarb J, Walcott J and Green JP (1991) Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther 256:341-347.
12. 4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: Effect of substituted benzamide derivatives. Mol Pharmacol 37:408-411.
13. Bowen D, Allen SJ, Benton SJ, Goodhardt MJ, Haan EA, Plamer AM, Sims NR, Smith CCT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK and Davison AN (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 41:266-272.
14. Cassel J-C and Jeltsch H (1995) Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications. Neuroscience 69:1-41.
15. 3 receptor subtypes. Br J Pharmacol 107:919-923.
16. 1B receptors. J Pharmacol Exp Ther 277:823-830.
17. 3 receptors. J Neurochem 62:2254-2261.
18. 2 receptor subtypes. J Pharmacol Exp Ther 277:775-783.
19. 3 receptors are membrane ion channels. Nature 339:706-709.
20. Donatsch P, Engel G, Richardson BP and Stadler PA (1984) ICS 205-930: A highly selective and potent antagonist at peripheral neuronal 5-hydroxytryptamine (5-HT) receptors. Br J Pharmacol 81:34P.
21. Dudel J and Hatt H (1976) Four types of GABA receptors in crayfish leg muscles characterized by desensitization and specific antagonist. Pflüger Arch 364:217-222.
22. Dumuis A, Bouhelal R, Sebben M, Cory R and Bockaert J (1988) A non-classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880-887.
23. Elliott P and Wallis DI (1988) The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves. Nauyn-Schmiedeberg Pharmacol 338:608-615.
24. 3 receptors, in Cardiovascular Pharmacology of 5-Hydroxytryptamine (Saxena PR, Wallis DI, Woutersand W and Bevan P eds) pp 101-115, Kluwer, Dordrecht, the Netherlands.
25. +-evoked release of acetylcholine from rat cortex in vivo. Inflamm Res 46:S3-S4.
26. Giovannini MG, Mutolo D, Bianchi L, Michelassi A and Pepeu G (1994) NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci 14: 1358-1365.
27. Goldfarb J, Walcott J and Blandina P (1993) Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus. J Pharmacol Exp Ther 267:45-50.
28. Green JP, Johnson CL, Weinstein H and Maayani S (1977) Antagonism of histamine-activated adenylate cyclase in brain by d-lysergic acid diethylamide. Proc Natl Acad Sci USA 74:5697-5601.
29. Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, Hakansson L, Nordberg A and Ungerstedt U (1990) Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neurosci Lett 110:172-179.
30. Hirano H, Day J and Fibiger HC (1995) Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 65:1139-1145.
31. Ireland SJ and Tyers MB (1987) Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90:229-238.
32. 2 receptors in human leukemia cells. Adv Biosci 51:79-88.
33. 2 receptors coupled to cardiac adenylate cyclase. Effects of guanylnucleotides and structural requirements for agonistic activity. Biochim Biophys Acta 587:155-168.
34. 3 receptor ligands lack modulatory influence on acetylcholine release in rat enthorhinal cortex. Naunyn-Schmiedeberg Arch Pharmacol 347:241-247.
35. 3 receptor agonist. Eur J Pharmacol 182: 193-197.
36. 3 receptors. Naunyn Schmiedeberg's Arch Pharmacol 342:22-30.
37. 3 receptors in rat brain using radioligand binding. Nature 330:746-748.
38. Lidov HG, Grzanna R and Molliver ME (1980) The serotonin innervation of the cerebral cortex in rat - an immunohistochemical analysis. Neuroscience 5:207-227.
39. 3 receptors in the control of 5-HT release in rat hippocampus in vivo. Br J Pharmacol 106:139-142.
40. 3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J Neurochem 58:2334-2337.
41. Mesulam MM, Mufson EJ, Wainer BH and Levey AI (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10:1185-1201.
42. Milner TA and Veznedaroglu E (1993) Serotonin-containing terminals synapse on septohippocampal neurons in the rat. J Neurosci Res 36:260-271.
43. Moore RY, Hilaris AE and Jones BE (1978) Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 180:417-438.
44. Neijt HC, Duits IJT and Vijverberg HPM (1988) Pharmacological characterization of serotonin 5-HT3 receptor-media ted electrical response in cultured mouse neuroblastoma cells. Neuropharmacology 27:301-307.
45. Parkins HJ, Cheng CHK, Costall B and Naylor RJ (1994) Effect of 5-HT3 receptor ligands on in vivo acetylcholine release from the rat hippocampus. Br J Pharmacol Suppl. 315 P.
46. 3 receptor antagonist, in the treatment of central nervous system disorders. CNS Drug Rev 2:195-213.
47. 3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol 103:1790-1794.
48. Paxinos G and Watson C (1982). The Rat Brain in Stereotaxic Coordinates. New York, Academic Press.
49. 3 receptor distribution in the rat CNS. Abs Soc Neurosci 23:1215.
50. 2-muscarinic receptor antagonist in aged memory-impaired rats. J Neurosci 15:1455-1462.
51. 3 receptors, in Neuronal Serotonin (Osborne NN and Hamon M eds) pp 465-506, John Wiley & Sons, New York, NY.
52. Richardson BP, Engel G, Donatsch P and Stadler PA (1985) Identification of 5-hydroxytryptamine M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126-131.
53. Ropert N and Guy N (1991) Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol 441:121-136.
54. Schlicker E, Betz R and Göthert M (1989) Investigation into the age-dependence of release of serotonin and noradrenaline in the rat brain cortex and of autoreceptor-mediated modulation of release. Neuropharmacology 28:811-815.
55. 3 receptors in rat amygdala. Neuron 8:199-203.
56. 1-like receptor. Br J Pharmacol 107:322-328.
57. 3 receptor mRNA. Proc Natl Acad Sci USA 90:1430-1434.
58. 3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Res 511:71-79.
59. Wallis D and Nash H (1981) Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells. Eur J Pharmacol 70:381-386.
60. Wallis DI and Dun NJ (1988) A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro. Br J Pharmacol 93:110-120.
61. Wenk GL, Pierce DJ, Struble RG, Price DL and Cork LC (1989) Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging 10: 11-19.
62. Westerink BHC, Damsa G, Rolema H, DeVries JB and Horn AS (1987) Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems. Life Sci 41:1763-1776.
63. Westerink BHC and deVries JB (1966) A new method to estimate the migration rate of centrally acting drugs from microdialysis probes through brain tissues in conscious animals, in Monitoring Molecules in Neuroscience (Gonzáles-Mora JL, Borgesand R and Msa M eds) pp 9-10, University of La Laguna, Tenerife, SP.
64. 3 recognition sites in rat cerebral cortex. Eur J Pharmacol 166:107-110.
65. 3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1:615-621.
66. Zifa E and Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401-458.